Electra Therapeutics IPO priced at midpoint; raises $350 million
Electra Therapeutics upsized its IPO and priced it at the midpoint of expectations, raising $350 million. Shares are set to debut Friday.
Electra Therapeutics is set to begin trading Friday after the clinical-stage biopharmaceutical company priced its upsized initial public offering at the midpoint of the expected range, raising $350 million. , company said late Thursday...